Abstract
We report our clinical experience on the effect of Scrambler Therapy (ST) for a child with acute mixed pain refractory to pharmacological treatment. ST, recently proposed as an alternative treatment for chronic neuropathic pain in adults, is a noninvasive approach to relieve pain, by changing pain perception at brain level. It is safe and has no side effects. Further research is needed to assess its efficacy for acute pain and for paediatric population.
Highlights
Scrambler Therapy (ST) is a noninvasive and fully automated medical device for pain treatment, approved by the Food and Drug Administration (FDA)
It has been used in adults to treat chronic pain, mainly neuropathic pain [1,2,3,4,5,6] and untreatable cancer pain [6,7,8,9,10]
The authors concluded that a 45-minute daily treatment with ST for 10 days is effective in pain alleviation [6]
Summary
Scrambler Therapy (ST) is a noninvasive and fully automated medical device for pain treatment, approved by the Food and Drug Administration (FDA). It provides cutaneous electrostimulation with surface electrodes placed surrounding the pain area, in order to replace “pain” signals with “nopain” signals. It has been used in adults to treat chronic pain, mainly neuropathic pain (postherpetic neuralgia, spinal cord stenosis, and chemotherapy-induced peripheral neuropathy) [1,2,3,4,5,6] and untreatable cancer pain [6,7,8,9,10]. We report our clinical experience using ST in a situation never experimented before: acute pain treatment in a paediatric patient
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
